Mode
Text Size
Log in / Sign up
N/A Completed N=79 Randomized Quadruple-blind Treatment

Treatment of Androgenic Alopecia in Males

androgenetic alopecia · Hair Loss · Male Pattern Baldness
Source: ClinicalTrials.gov NCT00947219 ↗
Enrolled (actual)
79
Serious AEs
0.0%
Results posted
Jan 2013
Primary outcomePrimary: Changes in Terminal Hair Count at 16 and 26 Weeks Compared to Baseline in Men Diagnosed With Androgenetic Alopecia — 23.5; 20.4; 4.4; 25.7 hairs per cm^2

Summary

The purpose of this study is to evaluate the change in terminal hair count at 16 and 26 weeks compared to baseline measurements.

Outcome Measures

OutcomeResultp-value
PRIMARY
Changes in Terminal Hair Count at 16 and 26 Weeks Compared to Baseline in Men Diagnosed With Androgenetic Alopecia
23.5; 20.4; 4.4; 25.7; 20.9; 9.4

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of androgenetic alopecia
  • Fitzpatrick Skin Types I-IV
  • Norwood-Hamilton IIa to V
  • Active hair loss within last 12 months

Exclusion Criteria

  • Photosensitivity to laser light
  • Malignancy in the target area
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00947219). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search